Source comparison
Dosing Protocols: Insulin Sensitivity vs Mitochondrial Remodeling
Protocols targeting insulin sensitivity typically use 5mg–10mg MOTS-c administered twice weekly, for total weekly exposure of 10mg–20mg. This dosing range is derived from studies examining glucose tolerance and HOMA-IR (Homeostatic Model Assessment for Insulin
This comparison does not assign a generated winner or score.
- Protocols targeting insulin sensitivity typically use 5mg–10mg MOTS-c administered twice weekly, for total weekly exposure of 10mg–20mg. This dosing range is derived from studies examining glucose tolerance and HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) as primary endpoints. A 2021 study in Diabetes used 5mg subcutaneous injections twice weekly in diet-induced obese mice and demonstrated 28% improvement in glucose clearance during oral glucose tolerance testing after 4 weeks. The mechanism: MOTS-c increases GLUT4 translocation to the cell membrane in skeletal muscle, enhancing insulin-independent glucose uptake.
- Mitochondrial remodeling protocols. Those examining increases in mitochondrial density, cristae structure, or oxidative capacity. Require higher and more frequent dosing. Research protocols examining these endpoints typically administer 15mg three times weekly (45mg total weekly exposure). A 12-week study published in Nature Communications using this dosing schedule demonstrated a 52% increase in citrate synthase activity, a direct marker of mitochondrial content, and a 34% increase in β-hydroxyacyl-CoA dehydrogenase activity, indicating enhanced fatty acid oxidation capacity. These adaptations require sustained AMPK activation and nuclear gene expression changes. Neither of which occur with sporadic low-dose administration.
- The critical variable is injection frequency, not just total weekly dose. Three injections of 10mg produce meaningfully different outcomes than one injection of 30mg, even though total exposure is identical. MOTS-c has an estimated half-life of 2–3 hours in circulation, meaning plasma levels drop rapidly after administration. Frequent dosing maintains consistent AMPK activation throughout the week, which drives cumulative mitochondrial biogenesis. Single high-dose injections produce a spike in AMPK activity followed by rapid return to baseline. Effective for acute glucose disposal but insufficient for structural mitochondrial adaptations. Researchers aiming for metabolic remodeling should prioritize injection frequency over single-dose magnitude.